135 related articles for article (PubMed ID: 17785293)
1. Human proteinase 3 (PR3) and its binding molecules: implications for inflammatory and PR3-related autoimmune responses.
Müller A; Voswinkel J; Gottschlich S; Csernok E
Ann N Y Acad Sci; 2007 Aug; 1109():84-92. PubMed ID: 17785293
[TBL] [Abstract][Full Text] [Related]
2. Interaction of proteinase 3 with its associated partners: implications in the pathogenesis of Wegener's granulomatosis.
Witko-Sarsat V; Reuter N; Mouthon L
Curr Opin Rheumatol; 2010 Jan; 22(1):1-7. PubMed ID: 19881350
[TBL] [Abstract][Full Text] [Related]
3. A study of conformational restraints on reactivity of human PR3-specific autoantibodies (ANCA) facilitated through protein folding manipulations of a new recombinant proteinase 3 protein.
Farrag L; Pendergraft WF; Yang JJ; Jennette JC; Falk RJ; Preston GA
Autoimmunity; 2007 Nov; 40(7):503-11. PubMed ID: 17966040
[TBL] [Abstract][Full Text] [Related]
4. Mapping of conformational epitopes on human proteinase 3, the autoantigen of Wegener's granulomatosis.
Kuhl A; Korkmaz B; Utecht B; Kniepert A; Schönermarck U; Specks U; Jenne DE
J Immunol; 2010 Jul; 185(1):387-99. PubMed ID: 20530264
[TBL] [Abstract][Full Text] [Related]
5. Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies.
Brachemi S; Mambole A; Fakhouri F; Mouthon L; Guillevin L; Lesavre P; Halbwachs-Mecarelli L
J Am Soc Nephrol; 2007 Aug; 18(8):2330-9. PubMed ID: 17634439
[TBL] [Abstract][Full Text] [Related]
6. Computational prediction of the binding site of proteinase 3 to the plasma membrane.
Hajjar E; Mihajlovic M; Witko-Sarsat V; Lazaridis T; Reuter N
Proteins; 2008 Jun; 71(4):1655-69. PubMed ID: 18076025
[TBL] [Abstract][Full Text] [Related]
7. Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener's granulomatosis.
Csernok E; Holle JU; Gross WL
Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S112-7. PubMed ID: 18799068
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to proteinase 3 prime human oral, lung, and kidney epithelial cells to secrete proinflammatory cytokines upon stimulation with agonists to various Toll-like receptors, NOD1, and NOD2.
Uehara A; Hirabayashi Y; Takada H
Clin Vaccine Immunol; 2008 Jul; 15(7):1060-6. PubMed ID: 18495849
[TBL] [Abstract][Full Text] [Related]
9. Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's Granulomatosis.
Hu N; Westra J; Kallenberg CG
Autoimmun Rev; 2009 May; 8(6):510-4. PubMed ID: 19185066
[TBL] [Abstract][Full Text] [Related]
10. Functional significance of Asn-linked glycosylation of proteinase 3 for enzymatic activity, processing, targeting, and recognition by anti-neutrophil cytoplasmic antibodies.
Specks U; Fass DN; Finkielman JD; Hummel AM; Viss MA; Litwiller RD; McDonald CJ
J Biochem; 2007 Jan; 141(1):101-12. PubMed ID: 17158864
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
12. What you should know about PR3-ANCA. Structural aspects of antibodies to proteinase 3 (PR3).
Peen E; Williams RC
Arthritis Res; 2000; 2(4):255-9. PubMed ID: 11094437
[TBL] [Abstract][Full Text] [Related]
13. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases.
Lee AS; Finkielman JD; Peikert T; Hummel AM; Viss MA; Specks U
J Immunol Methods; 2005 Dec; 307(1-2):62-72. PubMed ID: 16242707
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of antineutrophil cytoplasmic antibodies in patients with cocaine-induced midline destructive lesions.
Peikert T; Finkielman JD; Hummel AM; McKenney ME; Gregorini G; Trimarchi M; Specks U
Arthritis Rheum; 2008 May; 58(5):1546-51. PubMed ID: 18438818
[TBL] [Abstract][Full Text] [Related]
15. Anti-proteinase 3 antibodies both stimulate and prime human neutrophils.
Uriarte SM; McLeish KR; Ward RA
Nephrol Dial Transplant; 2009 Apr; 24(4):1150-7. PubMed ID: 18952697
[TBL] [Abstract][Full Text] [Related]
16. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
17. Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases.
Korkmaz B; Jenne DE; Gauthier F
Int Immunopharmacol; 2013 Dec; 17(4):1198-205. PubMed ID: 23886601
[TBL] [Abstract][Full Text] [Related]
18. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis.
Damoiseaux J; Dähnrich C; Rosemann A; Probst C; Komorowski L; Stegeman CA; Egerer K; Hiepe F; van Paassen P; Stöcker W; Schlumberger W; Tervaert JW
Ann Rheum Dis; 2009 Feb; 68(2):228-33. PubMed ID: 18375539
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the CD177 interaction with the ANCA antigen proteinase 3.
Jerke U; Marino SF; Daumke O; Kettritz R
Sci Rep; 2017 Feb; 7():43328. PubMed ID: 28240246
[TBL] [Abstract][Full Text] [Related]
20. Proteinase 3 is an IL-32 binding protein.
Novick D; Rubinstein M; Azam T; Rabinkov A; Dinarello CA; Kim SH
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3316-21. PubMed ID: 16488976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
